Soluble endoglin modulates aberrant cerebral vascular remodeling - Wikidata - awgldk - TriplyDB

Soluble endoglin modulates aberrant cerebral vascular remodeling

Soluble endoglin modulates aberrant cerebral vascular remodeling

http://www.wikidata.org/entity/Q37411686

about

Increased plasma soluble endoglin levels as an indicator of cardiovascular alterations in hypertensive and diabetic patients Lacritin and other autophagy associated proteins in ocular surface health.Endoglin in liver fibrogenesis: Bridging basic science and clinical practice Endothelial follistatin-like-1 regulates the postnatal development of the pulmonary vasculature by modulating BMP/Smad signaling.Brain arteriovenous malformation modeling, pathogenesis, and novel therapeutic targets.Novel brain arteriovenous malformation mouse models for type 1 hereditary hemorrhagic telangiectasia.Perlecan domain V is upregulated in human brain arteriovenous malformation and could mediate the vascular endothelial growth factor effect in lesional tissue Cytochrome P450 and matrix metalloproteinase genetic modifiers of disease severity in Cerebral Cavernous Malformation type 1.Hypoxia-inducible factor-1α and vascular endothelial growth factor in the cardioprotective effects of intermittent hypoxia in rats.Endothelial signaling and the molecular basis of arteriovenous malformation.The physiological role of endoglin in the cardiovascular system.TGFβ signaling and cardiovascular diseases.Mouse models of hereditary hemorrhagic telangiectasia: recent advances and future challenges.Pathogenesis of Brain Arteriovenous Malformations.An early venous abnormality: a potential cause of arteriovenous malformation recurrence.The roles of endoglin gene in cerebrovascular diseases.MicroRNA-137 and microRNA-195* inhibit vasculogenesis in brain arteriovenous malformations.Soluble endoglin regulates expression of angiogenesis-related proteins and induction of arteriovenous malformations in a mouse model of hereditary hemorrhagic telangiectasia

P2860

Q24619354-CCAA97D6-1960-49CC-8EEC-B68E4E437590 Q30278788-A6F4F2C8-C624-47D9-A2E1-4A812651B8EB Q33728841-36CFF9F8-583E-4E48-A2E8-F057F55F1CE7 Q33738647-14E2BB78-679F-441F-B74B-73D0F2B852A4 Q33843008-E5FDA8AC-A2A3-4EAA-BEF9-1E008905E26D Q35092843-D0CA31DF-F53C-4B66-9668-37CBA13BF050 Q36503807-D172C2EE-8E76-4916-B811-09AEF0B0FE05 Q36641687-34D79301-7AA1-462D-A8D3-436C66BD45E1 Q36787101-90D18EE2-84A9-4978-BFEF-36F4DA6F50BC Q37671796-98FBB8C3-87CF-4ADA-B93F-5811329BCCC1 Q37775427-B524039F-4545-44C2-A655-3A124F82C7DF Q37976673-22FF1513-3839-442C-B2B5-CEF891EE4239 Q38367817-D4D453FF-B9ED-4073-9EF8-0F3A6A72A000 Q39852529-B2A9A6F6-C1CE-492A-B2CF-72E894998A96 Q41873261-B46BD892-3FB8-4891-8364-BC8934D24394 Q46528698-DB49B3EC-F565-4FB4-8933-2B92ECE24E59 Q47802041-03F7A5E8-BAD3-4822-9C50-522978C6F44A Q58703191-151A2F06-C65A-4146-B227-FCC9955D5AAB

P2860

Soluble endoglin modulates aberrant cerebral vascular remodeling

http://www.wikidata.org/entity/Q37411686

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on July 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Soluble endoglin modulates aberrant cerebral vascular remodeling

@en

Soluble endoglin modulates aberrant cerebral vascular remodeling.

@nl

type

label

Soluble endoglin modulates aberrant cerebral vascular remodeling

@en

Soluble endoglin modulates aberrant cerebral vascular remodeling.

@nl

prefLabel

Soluble endoglin modulates aberrant cerebral vascular remodeling

@en

Soluble endoglin modulates aberrant cerebral vascular remodeling.

@nl

P1433

Q37411686-CBC320F4-BD70-4FBA-A2E2-87EB5242C194

P1476

Q37411686-58AD1874-7666-495B-BBEA-D12100BBEBE9

P2093

Q37411686-04206EA8-F6F3-4FB5-AD82-E05B2D771491

Q37411686-0BECB5D0-B9A5-4B11-A3DB-A897BEA1CC66

Q37411686-0F97610E-CC12-4E0C-A73E-BF6578C3BC48

Q37411686-1C0F9DE6-3262-49D6-9041-F6BE2C47AA7F

Q37411686-1F3BCA1B-5C23-4237-9999-DF78C12FBE88

Q37411686-36A7217A-00DC-442E-9433-A9B45D01DD55

Q37411686-B76BAC04-AEAF-4919-9E57-E68B9B61D539

Q37411686-B8E0CB65-3FD4-4E97-8D75-AAAD0EC5F7E5

Q37411686-F7FB6F1D-B3DB-44BD-BB3A-EF0F18C73C49

P2860

Q37411686-024919FC-FD3A-4766-AC5D-C8710BAA8DD0

Q37411686-05DDFEFB-0C3C-4DB8-ABB7-8A9648560405

Q37411686-074CF6B5-C048-45AF-BD06-C1E6AF978AE8

Q37411686-0E8D99C0-5640-48E2-906E-1BC74EED6FB4

Q37411686-15E1B0FD-FAFA-4670-A2B9-12A4BC7C6FD5

Q37411686-21F3D877-CAAB-4014-B8B4-E3F4E18B6235

Q37411686-221510ED-80A4-4156-A3E5-A516156544DB

Q37411686-254DB632-452A-4202-BB89-959CB7328599

Q37411686-2F4EA2F4-09FC-4178-A46B-4E9FF4D6E72E

Q37411686-36A0EE84-D100-4B36-9D4D-78CC0A1EC9DB

P304

Q37411686-F82FDFD1-AA69-4F7D-AFCC-41E1172A0F0E

P31

Q37411686-25C2995B-66A1-47CA-88CD-C446E588F93F

P356

Q37411686-DCE59B7C-8E33-472F-BF91-82CBDA766168

P433

Q37411686-756D1600-AA47-46E7-A26A-7FA6FE9DE330

P478

Q37411686-0DEBD9F3-BC1C-4419-8FE3-6B091BF0DE43

P50

Q37411686-A6D0DE79-D0E1-4815-816D-447DD07C0E94

P577

Q37411686-0CC5AA80-D905-43D6-BDF8-EEC361E42F3A

P5875

Q37411686-D32C12A4-A06B-477F-BDD7-C2713B42656B

P698

Q37411686-1C34E039-DE71-4DCB-B449-FA7CCC76B15A

P932

Q37411686-6CD9AB8E-AAE8-4773-82B2-E4B295EEC636

P356

P1433

Annals of Neurology

P1476

Soluble endoglin modulates aberrant cerebral vascular remodeling

@en

P2093

Guo-Yuan Yang

http://www.w3.org/2001/XMLSchema#string

Helen Kim

http://www.w3.org/2001/XMLSchema#string

Hua Su

http://www.w3.org/2001/XMLSchema#string

Michelle Letarte

http://www.w3.org/2001/XMLSchema#string

Nicholas M Barbaro

http://www.w3.org/2001/XMLSchema#string

Qi Hao

http://www.w3.org/2001/XMLSchema#string

S Ananth Karumanchi

http://www.w3.org/2001/XMLSchema#string

William L Young

http://www.w3.org/2001/XMLSchema#string

Yongmei Chen

http://www.w3.org/2001/XMLSchema#string

P2860

Endoglin is an accessory protein that interacts with the signaling receptor complex of multiple members of the transforming growth factor-beta superfamily

Endoglin, a TGF-beta binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1

Suppression of MMP-9 by doxycycline in brain arteriovenous malformations

Soluble endoglin contributes to the pathogenesis of preeclampsia

Retroviral delivery of homeobox D3 gene induces cerebral angiogenesis in mice

Arteriovenous malformations of the brain in adults.

Vascular morphogenesis: tales of two syndromes.

Endoglin expression is reduced in normal vessels but still detectable in arteriovenous malformations of patients with hereditary hemorrhagic telangiectasia type 1.

Increased tissue perfusion promotes capillary dysplasia in the ALK1-deficient mouse brain following VEGF stimulation.

Common variants in interleukin-1-Beta gene are associated with intracranial hemorrhage and susceptibility to brain arteriovenous malformation.

P304

19-27

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/ANA.21710

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

66

http://www.w3.org/2001/XMLSchema#string

P50

Michael T Lawton

P577

2009-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26731997

http://www.w3.org/2001/XMLSchema#string

P698

19670444

http://www.w3.org/2001/XMLSchema#string

P932

2773229

http://www.w3.org/2001/XMLSchema#string